Related Experiment Video
Updated: Dec 8, 2025
04:24
A Novel Digital Platform for a Monitored Home-based Cardiac Rehabilitation Program
Published on: April 19, 2019
12.1K
Effect of Voluntary Participation on Mobile Health Care in Diabetes Management: Randomized Controlled Open-Label
Da Young Lee1,2, Seung-Hyun Yoo2,3, Kyong Pil Min4
1Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
JMIR Mhealth and Uhealth
|September 18, 2020
Summary
Mobile health (mHealth) interventions improved glycemic control and diabetes self-management skills. Voluntary participation enhanced these positive effects in individuals with diabetes.
Area of Science:
- Diabetes Management
- Mobile Health Interventions
- Health Psychology
Background:
- While mobile health (mHealth) has been studied for glycemic control, its impact on self-management skills and psychological aspects remains underexplored.
- Previous research has primarily focused on the clinical outcomes of mHealth in diabetes care.
Purpose of the Study:
- To evaluate the efficacy of mHealth-based diabetes self-management education.
- To assess the influence of voluntary participation on the effectiveness of mHealth interventions.
Main Methods:
- A 6-month randomized controlled trial involving 66 participants.
- Intervention group received mHealth education via a mobile app and professional feedback; control group maintained standard care.
- Primary outcome: change in glycated hemoglobin (HbA1c); secondary outcomes: BMI, blood pressure, lipid profile, and quality of life/self-care questionnaires.
Main Results:
- Significant improvements in HbA1c, total cholesterol, and diabetes-related distress (Problem Areas in Diabetes scores) were observed in the intervention group.
- Participants showed marked increases in diet adherence and self-monitoring of blood glucose levels.
- These benefits were particularly pronounced in self-motivated participants recruited voluntarily.
Conclusions:
- mHealth-based diabetes self-management education is effective in enhancing glycemic control.
- mHealth interventions improve diabetes self-management skills and reduce psychological distress.
- Voluntary participation may amplify the positive outcomes of mHealth in diabetes care.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
762
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
762
01:22Diabetes Mellitus: Type 2 and Gestational
4.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.1K
01:11Blinding
3.7K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.7K
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
70
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
70